Frédéric Limosin, MD, PhD

Centre Ressource Régional de Psychiatrie du Sujet Agé (CRRPSA), Service de Psychiatrie et d’Addictologie de l’adulte et du sujet âgé, DMU Psychiatrie et Addictologie, AP-HP, Centre-Université de Paris, Paris, France; Université de Paris, Paris, France; Inserm U1266, Institut de Psychiatrie et Neurosciences de Paris, Paris, France

Letter to the Editor

Adulthood Self-Reported Cardiovascular Risk and ADHD Medications: Results From the 2004–2005 National Epidemiologic Survey on Alcohol and Related Conditions

February 15, 2014

Hugo Peyre, Nicolas Hoertel, Hanna Hatteea, et al

Original Research

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

February 4, 2014

Nicolas Hoertel, Bruno Falissard, Keith Humphreys, et al

Letter to the Editor

Long-Term Effects of ADHD Medication on Adult Height: Results From the NESARC

November 15, 2013

Hugo Peyre, Nicolas Hoertel, Samuele Cortese, et al

Article

Generalizability in Bipolar Treatment Trials

March 15, 2013

Read a full article on the generalizability in bipolar treatment and how they should carefully consider the impact of eligibility criteria.

Nicolas Hoertel, Yann Le Strat, Pierre Lavaud, et al

Letter to the Editor

Two-Year Follow-Up of a Patient With Successful Continuation of Clozapine Treatment Despite Morning Pseudoneutropenia

September 1, 2004

David Esposito, Jérémie Aouillé, Frédéric Rouillon, et al

« 1 2